Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001047469-19-001206
Filing Date
2019-03-14
Accepted
2019-03-14 06:02:59
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3/A a2238055zs-3a.htm S-3/A 167560
2 EX-5.1 a2238055zex-5_1.htm EX-5.1 10804
3 EX-23.1 a2238055zex-23_1.htm EX-23.1 3597
4 G227642.JPG g227642.jpg GRAPHIC 24289
5 G396757.JPG g396757.jpg GRAPHIC 7806
6 G421744.JPG g421744.jpg GRAPHIC 8658
  Complete submission text file 0001047469-19-001206.txt   239792
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-228910 | Film No.: 19679658
SIC: 2836 Biological Products, (No Diagnostic Substances)